How do you choose the appropriate migraine pharmacotherapy for an elderly person?
01 Pubblicazione su rivista
Curto Martina, Capi Matilde, Martelletti Paolo, Lionetto Luana
ISSN: 1465-6566
Migraine is ranked as the third most prevalent disorder, the eight
most burdensome disease and the seventh cause of disability
worldwide [1]. Although its prevalence decreases after the age of
60, it still affects 7% of women and 3% of men over 65. A successful
treatment of a late-life migraine is particularly important due to the
association with increased risk of ischemic stroke, white matter
lesions and other transient neurological phenomena (migraine
accompaniments) responsive to prophylactic medications